IMC Chicago’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Sell
141,300
-44,800
-24% -$536K ﹤0.01% 3084
2026
Q1
$1.11M Sell
186,100
-60,100
-24% -$452K ﹤0.01% 3163
2025
Q4
$1.77M Buy
246,200
+19,400
+9% +$153K ﹤0.01% 2533
2025
Q3
$2.42M Buy
226,800
+93,900
+71% +$922K ﹤0.01% 2089
2025
Q2
$1.29M Buy
132,900
+69,400
+109% +$716K ﹤0.01% 2308
2025
Q1
$946K Buy
63,500
+20,000
+46% +$308K ﹤0.01% 2310
2024
Q4
$649K Buy
43,500
+2,400
+6% +$39.1K ﹤0.01% 2610
2024
Q3
$786K Buy
41,100
+17,900
+77% +$371K ﹤0.01% 2166
2024
Q2
$480K Sell
23,200
-4,200
-15% -$83.5K ﹤0.01% 2301
2024
Q1
$515K Buy
+27,400
New +$470K ﹤0.01% 2030

Other funds holding OGN

IMC Chicago's OGN Position: Q2 2026 in Review

IMC Chicago sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 47,531 shares — an estimated $568K sold.

IMC Chicago first reported a position in OGN in Q1 2024 and held it in 4 quarters. The position peaked at $1.3M in Q4 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • IMC Chicago reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 47,531 Organon & Co shares in Q2 2026, an estimated $568K.
  • IMC Chicago first reported a position in Organon & Co in Q1 2024 and held it in 4 quarters.
  • IMC Chicago's Organon & Co position peaked at $1.3M in Q4 2024.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.